Mithil Pradhan of Violet Arch Capital Advisors says that we are advising clients to short Ranabxy and buy any pharma stock. It could be something like Sun Pharma or Dr Reddy's or it could be simply sell Ranbaxy and Nifty. With the exception of Ranbaxy more or less we continue to remain bullish on all the pharma names in the sector.
first published: Jun 7, 2013 06:31 pm
A collection of the most-viewed Moneycontrol videos.
